Literature DB >> 28133768

Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels - a review of routine practice.

Naomi Jessurun1, Eugène P van Puijenbroek1,2, Leila S Otten3, Oenone Mikes4, Annemieke Vermeulen Windsant5, Rob J van Marum5,6, Koen Grootens4, Hieronymus J Derijks5,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28133768      PMCID： PMC5401965          DOI： 10.1111/bcp.13201

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry.

Authors:  E Berm; R Kok; E Hak; B Wilffert
Journal:  Pharmacopsychiatry       Date:  2016-04-21       Impact factor: 5.788

2.  The Concise Guide to PHARMACOLOGY 2015/16: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

3.  Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.

Authors:  L S Schneider; T B Cooper; J A Severson; T Zemplenyi; R B Sloane
Journal:  J Clin Psychopharmacol       Date:  1988-12       Impact factor: 3.153

4.  Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.

Authors:  K Laine; G Tybring; S Härtter; K Andersson; J O Svensson; J Widén; L Bertilsson
Journal:  Clin Pharmacol Ther       Date:  2001-10       Impact factor: 6.875

Review 5.  Optimizing the use of thiopurines in inflammatory bowel disease.

Authors:  Rishi M Goel; Paul Blaker; Alex Mentzer; Steven C M Fong; Anthony M Marinaki; Jeremy D Sanderson
Journal:  Ther Adv Chronic Dis       Date:  2015-05       Impact factor: 5.091

6.  Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials.

Authors:  Xiaojie Huang; Yuanlong Xu; Qiuying Yang; Jieqing Chen; Tong Zhang; Zaicun Li; Caiping Guo; Hui Chen; Hao Wu; Ning Li
Journal:  Sci Rep       Date:  2015-02-23       Impact factor: 4.379

7.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.

Authors:  Christopher Southan; Joanna L Sharman; Helen E Benson; Elena Faccenda; Adam J Pawson; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Michael Spedding; William A Catterall; Doriano Fabbro; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971
  7 in total
  1 in total

1.  Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers.

Authors:  Naomi T Jessurun; Petal A Wijnen; Aalt Bast; Eugène P van Puijenbroek; Otto Bekers; Marjolein Drent
Journal:  Int J Mol Sci       Date:  2020-04-16       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.